The Effect of Pentoxifylline on Oxidative Stress in Chronic Kidney Disease Patients With Erythropoiesis-Stimulating Agent Hyporesponsiveness: Sub-Study of the HERO Trial
Redox Report - United Kingdom
doi 10.1179/1351000215y.0000000022
Full Text
Open PDFAbstract
Available in full text
Date
January 2, 2016
Authors
Publisher
Informa UK Limited